Arteriosclerosis, Vol 10, 336-349, Copyright © 1990 by American Heart Association

ARTICLES

Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits

ME Rosenfeld, W Palinski, S Yla-Herttuala, S Butler and JL Witztum
Department of Medicine, University of California-San Diego, La Jolla 92093.

Antisera and monoclonal antibodies generated against autologous malondialdehyde-conjugated low density lipoprotein (MDA-LDL), 4- hydroxynonenal conjugated LDL (4-HNE-LDL), and the protein fragments of apoprotein B resulting from the copper oxidation of LDL, as well as antibodies against apoprotein B, were used to immunostain atherosclerotic lesions of varying severity from Watanabe heritable hyperlipemic rabbits. In macrophage-rich fatty streaks and transitional lesions, all of the antibodies recognizing oxidation specific epitopes exhibited predominantly cell-associated staining in particulate and annular patterns. This is in contrast to the limited, extracellular, diffuse staining obtained with the antibodies recognizing apoprotein B. In more advanced lesions containing areas with reduced numbers of cells, there was increased extracellular, diffuse staining with the antibodies against oxidation specific epitopes and co-localization with apoprotein B. In addition, there were annular staining patterns associated with the necrotic core and increased staining of intimal and medial smooth muscle cells. We interpret these data as suggesting that in areas of lesions rich in macrophages, LDL is oxidized and taken up by the cells. In more advanced lesions that are relatively devoid of macrophages, both native and oxidized LDL, as well as oxidation products released from dead and decaying cells, are trapped in the matrix, out of reach of those cells capable of accumulating oxidized LDL.

This article has been cited by other articles:

				L. Belkacemi, S. A. Bainbridge, M. A. Dickinson, G. N. Smith, and C. H. Graham Glyceryl Trinitrate Inhibits Hypoxia/Reoxygenation-Induced Apoptosis in the Syncytiotrophoblast of the Human Placenta: Therapeutic Implications for Preeclampsia Am. J. Pathol., March 1, 2007; 170(3): 909 - 920. [Abstract] [Full Text] [PDF]

				V. Marcil, E. Delvin, A. T. Sane, A. Tremblay, and E. Levy Oxidative stress influences cholesterol efflux in THP-1 macrophages: Role of ATP-binding cassette A1 and nuclear factors Cardiovasc Res, December 1, 2006; 72(3): 473 - 482. [Abstract] [Full Text] [PDF]

				T. Wu, W. C. Willett, N. Rifai, I. Shai, J. E. Manson, and E. B. Rimm Is Plasma Oxidized Low-Density Lipoprotein, Measured With the Widely Used Antibody 4E6, an Independent Predictor of Coronary Heart Disease Among U.S. Men and Women? J. Am. Coll. Cardiol., September 5, 2006; 48(5): 973 - 979. [Abstract] [Full Text] [PDF]

				J. Nigro, N. Osman, A. M. Dart, and P. J. Little Insulin Resistance and Atherosclerosis Endocr. Rev., May 1, 2006; 27(3): 242 - 259. [Abstract] [Full Text] [PDF]

				A. Boullier, Y. Li, O. Quehenberger, W. Palinski, I. Tabas, J. L. Witztum, and Y. I. Miller Minimally Oxidized LDL Offsets the Apoptotic Effects of Extensively Oxidized LDL and Free Cholesterol in Macrophages Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1169 - 1176. [Abstract] [Full Text] [PDF]

				J. W. Heinecke Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander? J. Exp. Med., April 17, 2006; 203(4): 813 - 816. [Abstract] [Full Text] [PDF]

				C. Vindis, I. Escargueil-Blanc, M. Elbaz, B. Marcheix, M.-H. Grazide, K. Uchida, R. Salvayre, and A. Negre-Salvayre Desensitization of Platelet-Derived Growth Factor Receptor-{beta} by Oxidized Lipids in Vascular Cells and Atherosclerotic Lesions: Prevention by Aldehyde Scavengers Circ. Res., March 31, 2006; 98(6): 785 - 792. [Abstract] [Full Text] [PDF]

				P. Leppanen, S. Koota, I. Kholova, J. Koponen, C. Fieber, U. Eriksson, K. Alitalo, and S. Yla-Herttuala Gene Transfers of Vascular Endothelial Growth Factor-A, Vascular Endothelial Growth Factor-B, Vascular Endothelial Growth Factor-C, and Vascular Endothelial Growth Factor-D Have No Effects on Atherosclerosis in Hypercholesterolemic Low-Density Lipoprotein-Receptor/Apolipoprotein B48-Deficient Mice Circulation, August 30, 2005; 112(9): 1347 - 1352. [Abstract] [Full Text] [PDF]

				H. Arakawa, J.-Y. Qian, D. Baatar, K. Karasawa, Y. Asada, Y. Sasaguri, E. R. Miller, J. L. Witztum, and H. Ueno Local Expression of Platelet-Activating Factor-Acetylhydrolase Reduces Accumulation of Oxidized Lipoproteins and Inhibits Inflammation, Shear Stress-Induced Thrombosis, and Neointima Formation in Balloon-Injured Carotid Arteries in Nonhyperlipidemic Rabbits Circulation, June 21, 2005; 111(24): 3302 - 3309. [Abstract] [Full Text] [PDF]

				X. Liu, J. Wei, D. H. Peng, M. D. Layne, and S.-F. Yet Absence of Heme Oxygenase-1 Exacerbates Myocardial Ischemia/Reperfusion Injury in Diabetic Mice Diabetes, March 1, 2005; 54(3): 778 - 784. [Abstract] [Full Text] [PDF]

				T. Kumagai, N. Matsukawa, Y. Kaneko, Y. Kusumi, M. Mitsumata, and K. Uchida A Lipid Peroxidation-derived Inflammatory Mediator: IDENTIFICATION OF 4-HYDROXY-2-NONENAL AS A POTENTIAL INDUCER OF CYCLOOXYGENASE-2 IN MACROPHAGES J. Biol. Chem., November 12, 2004; 279(46): 48389 - 48396. [Abstract] [Full Text] [PDF]

				V. Ribas, J. L. Sanchez-Quesada, R. Anton, M. Camacho, J. Julve, J. C. Escola-Gil, L. Vila, J. Ordonez-Llanos, and F. Blanco-Vaca Human Apolipoprotein A-II Enrichment Displaces Paraoxonase From HDL and Impairs Its Antioxidant Properties: A New Mechanism Linking HDL Protein Composition and Antiatherogenic Potential Circ. Res., October 15, 2004; 95(8): 789 - 797. [Abstract] [Full Text] [PDF]

				N. Traverso, S. Menini, E. P. Maineri, S. Patriarca, P. Odetti, D. Cottalasso, U. M. Marinari, and M. A. Pronzato Malondialdehyde, a Lipoperoxidation-Derived Aldehyde, Can Bring About Secondary Oxidative Damage To Proteins J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2004; 59(9): B890 - B895. [Abstract] [Full Text] [PDF]

				S. Yamada, T. Funada, N. Shibata, M. Kobayashi, Y. Kawai, E. Tatsuda, A. Furuhata, and K. Uchida Protein-bound 4-hydroxy-2-hexenal as a marker of oxidized n-3 polyunsaturated fatty acids J. Lipid Res., April 1, 2004; 45(4): 626 - 634. [Abstract] [Full Text] [PDF]

				H. Itabe, M. Mori, Y. Fujimoto, Y. Higashi, and T. Takano Minimally Modified LDL Is an Oxidized LDL Enriched with Oxidized Phosphatidylcholines J. Biochem., September 1, 2003; 134(3): 459 - 465. [Abstract] [Full Text] [PDF]

				M. M. Anderson and J. W. Heinecke Production of N{varepsilon}-(Carboxymethyl)Lysine Is Impaired in Mice Deficient in NADPH Oxidase: A Role for Phagocyte-Derived Oxidants in the Formation of Advanced Glycation End Products During Inflammation Diabetes, August 1, 2003; 52(8): 2137 - 2143. [Abstract] [Full Text] [PDF]

				N. L. Tsakadze, S. Srivastava, S. O. Awe, A. S. O. Adeagbo, A. Bhatnagar, and S. E. D'Souza Acrolein-induced vasomotor responses of rat aorta Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H727 - H734. [Abstract] [Full Text] [PDF]

				N. Mackman How Do Oxidized Phospholipids Inhibit LPS Signaling? Arterioscler. Thromb. Vasc. Biol., July 1, 2003; 23(7): 1133 - 1136. [Full Text] [PDF]

				Y. Kawai, A. Saito, N. Shibata, M. Kobayashi, S. Yamada, T. Osawa, and K. Uchida Covalent Binding of Oxidized Cholesteryl Esters to Protein: IMPLICATIONS FOR OXIDATIVE MODIFICATION OF LOW DENSITY LIPOPROTEIN AND ATHEROSCLEROSIS J. Biol. Chem., May 30, 2003; 278(23): 21040 - 21049. [Abstract] [Full Text] [PDF]

				N. Ananyeva, A. Tjurmin, E. Saenko, and C. Haudenschild Low Density Lipoproteins Interact With Acidic Fibroblast Growth Factor and Modify Its Function Arterioscler. Thromb. Vasc. Biol., April 1, 2003; 23(4): 601 - 607. [Abstract] [Full Text] [PDF]

				C. J. Albert, A. K. Thukkani, R. M. Heuertz, A. Slungaard, S. L. Hazen, and D. A. Ford Eosinophil Peroxidase-derived Reactive Brominating Species Target the Vinyl Ether Bond of Plasmalogens Generating a Novel Chemoattractant, alpha -Bromo Fatty Aldehyde J. Biol. Chem., March 7, 2003; 278(11): 8942 - 8950. [Abstract] [Full Text] [PDF]

				H. F. Hoff, J. O'Neil, Z. Wu, G. Hoppe, and R. L. Salomon Phospholipid Hydroxyalkenals: Biological and Chemical Properties of Specific Oxidized Lipids Present in Atherosclerotic Lesions Arterioscler. Thromb. Vasc. Biol., February 1, 2003; 23(2): 275 - 282. [Abstract] [Full Text] [PDF]

				M. Aikawa, S. Sugiyama, C. C. Hill, S. J. Voglic, E. Rabkin, Y. Fukumoto, F. J. Schoen, J. L. Witztum, and P. Libby Lipid Lowering Reduces Oxidative Stress and Endothelial Cell Activation in Rabbit Atheroma Circulation, September 10, 2002; 106(11): 1390 - 1396. [Abstract] [Full Text] [PDF]

				J. Hulthe and B. Fagerberg Circulating Oxidized LDL Is Associated With Subclinical Atherosclerosis Development and Inflammatory Cytokines (AIR Study) Arterioscler. Thromb. Vasc. Biol., July 1, 2002; 22(7): 1162 - 1167. [Abstract] [Full Text] [PDF]

				S. Yamada, S. Kumazawa, T. Ishii, T. Nakayama, K. Itakura, N. Shibata, M. Kobayashi, K. Sakai, T. Osawa, and K. Uchida Immunochemical detection of a lipofuscin-like fluorophore derived from malondialdehyde and lysine J. Lipid Res., August 1, 2001; 42(8): 1187 - 1196. [Abstract] [Full Text] [PDF]

				P. X. Shaw, S. Horkko, S. Tsimikas, M.-K. Chang, W. Palinski, G. J. Silverman, P. P. Chen, and J. L. Witztum Human-Derived Anti-Oxidized LDL Autoantibody Blocks Uptake of Oxidized LDL by Macrophages and Localizes to Atherosclerotic Lesions In Vivo Arterioscler. Thromb. Vasc. Biol., August 1, 2001; 21(8): 1333 - 1339. [Abstract] [Full Text] [PDF]

				M. Y. Chang, S. Potter-Perigo, T. N. Wight, and A. Chait Oxidized LDL bind to nonproteoglycan components of smooth muscle extracellular matrices J. Lipid Res., May 1, 2001; 42(5): 824 - 833. [Abstract] [Full Text]

				H. Ogawa, H. Soejima, K. Takazoe, S. Miyamoto, I. Kajiwara, H. Shimomura, T. Sakamoto, M. Yoshimura, K. Kugiyama, M. Kimura, et al. Increased Autoantibodies Against Oxidized Low-Density Lipoprotein in Coronary Circulation in Patients with Coronary Spastic Angina Angiology, March 1, 2001; 52(3): 167 - 174. [Abstract] [PDF]

				J. Hulthe, O. Wiklund, E. Hurt-Camejo, and G. Bondjers Antibodies to Oxidized LDL in Relation to Carotid Atherosclerosis, Cell Adhesion Molecules, and Phospholipase A2 Arterioscler. Thromb. Vasc. Biol., February 1, 2001; 21(2): 269 - 274. [Abstract] [Full Text] [PDF]

				S. Tsimikas, W. Palinski, and J. L. Witztum Circulating Autoantibodies to Oxidized LDL Correlate With Arterial Accumulation and Depletion of Oxidized LDL in LDL Receptor-Deficient Mice Arterioscler. Thromb. Vasc. Biol., January 1, 2001; 21(1): 95 - 100. [Abstract] [Full Text] [PDF]

				J. Hulthe, L. Bokemark, and B. Fagerberg Antibodies to Oxidized LDL in Relation to Intima-Media Thickness in Carotid and Femoral Arteries in 58-Year-Old Subjectively Clinically Healthy Men Arterioscler. Thromb. Vasc. Biol., January 1, 2001; 21(1): 101 - 107. [Abstract] [Full Text] [PDF]

				B. S. Dhaliwal and U. P. Steinbrecher Cholesterol delivered to macrophages by oxidized low density lipoprotein is sequestered in lysosomes and fails to efflux normally J. Lipid Res., October 1, 2000; 41(10): 1658 - 1665. [Abstract] [Full Text]

				C. A. Slachta, V. Jeevanandam, B. Goldman, W. L. Lin, and C. D. Platsoucas Coronary Arteries from Human Cardiac Allografts with Chronic Rejection Contain Oligoclonal T Cells: Persistence of Identical Clonally Expanded TCR Transcripts from the Early Post-Transplantation Period (Endomyocardial Biopsies) to Chronic Rejection (Coronary Arteries) J. Immunol., September 15, 2000; 165(6): 3469 - 3483. [Abstract] [Full Text] [PDF]

				F. G. de Oliveira, C. L. Rossi, M. G. de Oliveira, M. J.A. Saad, and L. A. Velloso Effect of vitamin E supplementation on antibody levels against malondialdehyde modified LDL in hyperlipidemic hamsters Cardiovasc Res, August 18, 2000; 47(3): 567 - 573. [Abstract] [Full Text] [PDF]

				J. I. Heller, J. R. Crowley, S. L. Hazen, D. M. Salvay, P. Wagner, S. Pennathur, and J. W. Heinecke p-Hydroxyphenylacetaldehyde, an Aldehyde Generated by Myeloperoxidase, Modifies Phospholipid Amino Groups of Low Density Lipoprotein in Human Atherosclerotic Intima J. Biol. Chem., March 31, 2000; 275(14): 9957 - 9962. [Abstract] [Full Text] [PDF]

				S. Tsimikas, B. P. Shortal, J. L. Witztum, and W. Palinski In Vivo Uptake of Radiolabeled MDA2, an Oxidation-Specific Monoclonal Antibody, Provides an Accurate Measure of Atherosclerotic Lesions Rich in Oxidized LDL and Is Highly Sensitive to Their Regression Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 689 - 697. [Abstract] [Full Text] [PDF]

				M. O. Pentikainen, K. Oorni, and P. T. Kovanen Lipoprotein Lipase (LPL) Strongly Links Native and Oxidized Low Density Lipoprotein Particles to Decorin-coated Collagen. ROLES FOR BOTH DIMERIC AND MONOMERIC FORMS OF LPL J. Biol. Chem., February 25, 2000; 275(8): 5694 - 5701. [Abstract] [Full Text] [PDF]

				A. J. Brown, E. L. Mander, I. C. Gelissen, L. Kritharides, R. T. Dean, and W. Jessup Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells: accumulation of oxidized esters in lysosomes J. Lipid Res., February 1, 2000; 41(2): 226 - 237. [Abstract] [Full Text]

				M. P. J. de Winther, K. W. van Dijk, L. M. Havekes, and M. H. Hofker Macrophage Scavenger Receptor Class A : A Multifunctional Receptor in Atherosclerosis Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 290 - 297. [Abstract] [Full Text] [PDF]

				L. G. Fong and D. Le The Processing of Ligands by the Class A Scavenger Receptor Is Dependent on Signal Information Located in the Cytoplasmic Domain J. Biol. Chem., December 17, 1999; 274(51): 36808 - 36816. [Abstract] [Full Text] [PDF]

				B. Karten, H. Boechzelt, P. M. Abuja, M. Mittelbach, and W. Sattler Macrophage-enhanced formation of cholesteryl ester–core aldehydes during oxidation of low density lipoprotein J. Lipid Res., July 1, 1999; 40(7): 1240 - 1253. [Abstract] [Full Text]

				J. W. HEINECKE Mass spectrometric quantification of amino acid oxidation products in proteins: insights into pathways that promote LDL oxidation in the human artery wall FASEB J, July 1, 1999; 13(10): 1113 - 1120. [Abstract] [Full Text]

				S. C. Whitman, S. L. Hazen, D. B. Miller, R. A. Hegele, J. W. Heinecke, and M. W. Huff Modification of Type III VLDL, Their Remnants, and VLDL From ApoE-Knockout Mice by p-Hydroxyphenylacetaldehyde, a Product of Myeloperoxidase Activity, Causes Marked Cholesteryl Ester Accumulation in Macrophages Arterioscler. Thromb. Vasc. Biol., May 1, 1999; 19(5): 1238 - 1249. [Abstract] [Full Text] [PDF]

				J. S. Martens, M. Lougheed, A. Gomez-Munoz, and U. P. Steinbrecher A Modification of Apolipoprotein B Accounts for Most of the Induction of Macrophage Growth by Oxidized Low Density Lipoprotein J. Biol. Chem., April 16, 1999; 274(16): 10903 - 10910. [Abstract] [Full Text] [PDF]

				D. SUZUKI, T. MIYATA, N. SAOTOME, K. HORIE, R. INAGI, Y. YASUDA, K. UCHIDA, Y. IZUHARA, M. YAGAME, H. SAKAI, et al. Immunohistochemical Evidence for an Increased Oxidative Stress and Carbonyl Modification of Proteins in Diabetic Glomerular Lesions J. Am. Soc. Nephrol., April 1, 1999; 10(4): 822 - 832. [Abstract] [Full Text]

				A. M. Schmidt, S. D. Yan, J.-L. Wautier, and D. Stern Activation of Receptor for Advanced Glycation End Products : A Mechanism for Chronic Vascular Dysfunction in Diabetic Vasculopathy and Atherosclerosis Circ. Res., March 19, 1999; 84(5): 489 - 497. [Abstract] [Full Text] [PDF]

				S. Du Yan, Y. Shi, A. Zhu, J. Fu, H. Zhu, Y. Zhu, L. Gibson, E. Stern, K. Collison, F. Al-Mohanna, et al. Role of ERAB/L-3-Hydroxyacyl-coenzyme A Dehydrogenase Type II Activity in Abeta -induced Cytotoxicity J. Biol. Chem., January 22, 1999; 274(4): 2145 - 2156. [Abstract] [Full Text] [PDF]

				H. Maxeiner, J. Husemann, C. A. Thomas, J. D. Loike, J. E. Khoury, and S. C. Silverstein Complementary Roles for Scavenger Receptor A and CD36 of Human Monocyte-derived Macrophages in Adhesion to Surfaces Coated with Oxidized Low-Density Lipoproteins and in Secretion of H2O2 J. Exp. Med., December 21, 1998; 188(12): 2257 - 2265. [Abstract] [Full Text] [PDF]

				S. Freigang, S. Horkko, E. Miller, J. L. Witztum, and W. Palinski Immunization of LDL Receptor–Deficient Mice With Homologous Malondialdehyde-Modified and Native LDL Reduces Progression of Atherosclerosis by Mechanisms Other Than Induction of High Titers of Antibodies to Oxidative Neoepitopes Arterioscler. Thromb. Vasc. Biol., December 1, 1998; 18(12): 1972 - 1982. [Abstract] [Full Text] [PDF]

				R. S. Crawford, E. A. Kirk, M. E. Rosenfeld, R. C. LeBoeuf, and A. Chait Dietary Antioxidants Inhibit Development of Fatty Streak Lesions in the LDL Receptor–Deficient Mouse Arterioscler. Thromb. Vasc. Biol., September 1, 1998; 18(9): 1506 - 1513. [Abstract] [Full Text] [PDF]

				J. Hulthe, J. Wikstrand, A. Lidell, I. Wendelhag, G. K. Hansson, and O. Wiklund Antibody Titers Against Oxidized LDL Are Not Elevated in Patients With Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., August 1, 1998; 18(8): 1203 - 1211. [Abstract] [Full Text] [PDF]

				M. A. Ramos, M. Kuzuya, T. Esaki, S. Miura, S. Satake, T. Asai, S. Kanda, T. Hayashi, and A. Iguchi Induction of Macrophage VEGF in Response to Oxidized LDL and VEGF Accumulation in Human Atherosclerotic Lesions Arterioscler. Thromb. Vasc. Biol., July 1, 1998; 18(7): 1188 - 1196. [Abstract] [Full Text] [PDF]

				K. Uchida, M. Kanematsu, Y. Morimitsu, T. Osawa, N. Noguchi, and E. Niki Acrolein Is a Product of Lipid Peroxidation Reaction. FORMATION OF FREE ACROLEIN AND ITS CONJUGATE WITH LYSINE RESIDUES IN OXIDIZED LOW DENSITY LIPOPROTEINS J. Biol. Chem., June 26, 1998; 273(26): 16058 - 16066. [Abstract] [Full Text] [PDF]

				M. Ricote, J. Huang, L. Fajas, A. Li, J. Welch, J. Najib, J. L. Witztum, J. Auwerx, W. Palinski, and C. K. Glass Expression of the peroxisome proliferator-activated receptor gamma  (PPARgamma ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein PNAS, June 23, 1998; 95(13): 7614 - 7619. [Abstract] [Full Text] [PDF]

				D. A. Bird, R. K. Tangirala, J. Fruebis, D. Steinberg, J. L. Witztum, and W. Palinski Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice J. Lipid Res., May 1, 1998; 39(5): 1079 - 1090. [Abstract] [Full Text] [PDF]

				K. Uchida, M. Kanematsu, K. Sakai, T. Matsuda, N. Hattori, Y. Mizuno, D. Suzuki, T. Miyata, N. Noguchi, E. Niki, et al. Protein-bound acrolein: Potential markers for oxidative stress PNAS, April 28, 1998; 95(9): 4882 - 4887. [Abstract] [Full Text] [PDF]

				R. Kinscherf, R. Claus, M. Wagner, C. Gehrke, H. Kamencic, D. Hou, O. Nauen, W. Schmiedt, G. Kovacs, J. Pill, et al. Apoptosis caused by oxidized LDL is manganese superoxide dismutase and p53 dependent FASEB J, April 1, 1998; 12(6): 461 - 467. [Abstract] [Full Text]

R. Wu, Y. H. Huang, L. S. Elinder, and J. Frostegard Lysophosphatidylcholine Is Involved in the Antigenicity of Oxidized LDL Arterioscler